OVERVIEW

Tesofensine 500mcg (30 capsules) is a synthetic compound originally developed for neurological research and later studied for its potential role in weight management. It functions as a triple monoamine reuptake inhibitor, affecting dopamine, serotonin, and norepinephrine pathways in the brain. By influencing these neurotransmitters, Tesofensine has been observed in clinical research to reduce appetite and increase satiety, which may contribute to decreased caloric intake. Its mechanism differs from many traditional weight-loss agents because it acts centrally on appetite regulation rather than directly altering metabolism or nutrient absorption.

Each capsule containing 500 micrograms provides a measured low-dose format, with a 30-capsule supply typically representing a one-month course in research settings. Clinical trials have shown that Tesofensine may support significant weight reduction when combined with dietary and lifestyle interventions. However, it remains an investigational compound in many regions and is not widely approved for general medical use. Potential side effects reported in studies include dry mouth, insomnia, increased heart rate, elevated blood pressure, and mood changes. Because it affects central nervous system neurotransmitters and cardiovascular parameters, Tesofensine should only be used under the supervision of a qualified healthcare professional, with careful monitoring for safety and tolerability.